Press Room


Abbott Said to Agree to Pay $1.3 Billion for Depakote Suits
Published on October 26, 2011

Abbott Laboratories agreed to pay at least $1.3 billion to settle claims by the U.S. government and 24 states alleging the company illegally marketed its Depakote epilepsy drug, people familiar with the accords said. Read more…

FDA approves Onfi to treat severe type of seizures
Published on October 24, 2011

On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets (clobazam) for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. As Onfi is intended to treat a disease or condition that affects fewer than 200,000 people in the United […]

For Many, Epilepsy Surgery Effective Long-Term
Published on October 14, 2011

Almost half of the people who undergo surgery for epilepsy remain free of seizures 10 years later, a new study finds. Current practice is to treat patients with medication, and only when drugs can’t control seizures — often many years later — does a patient become a candidate for surgery. This study suggests that some patients with […]

Preterm birth linked to epilepsy risk in adults
Published on October 10, 2011

Adults who were born prematurely may have a higher risk of the seizure disorder epilepsy than those who were born full-term, a new study suggests. Read more…

Adjunctive antiepileptic drug treatment can lower risk of dying from a sudden unexpected death
Published on September 22, 2011

New research published online in The Lancet Neurology, found that epilepsy patients who receive additional treatment with anti-epileptic drugs (AEDs) have about a seven times lower risk of passing away from sudden unexpected death—the most common cause of death in epilepsy patients. Sudden unexplained death is 20 times more common in people with epilepsy than in the […]